Proportion of Direct Acting Oral Anticoagulants (DOACs) not prescribed as edoxaban by all Sub-ICB Locations

Why it matters: In January 2022 the NHS in England announced a national procurement programme for DOACs, which states:

The 2022-2023 PCN Investment and Impact Fund (IIF) now includes the following indicator:

Please note: as prescribing data does not contain patient information or indication, this measure uses prescription items of DOACs prescribed for all indications in primary care, and therefore will not exactly match the IIF indicator. measures also have a consistent way of visualising measures, where 'lower is better' and therefore in this case we show the proportion of DOACs which are NOT prescribed as edoxaban.

Description: Percentage DOACs items not prescribed as edoxaban


Tagged as: Cardiovascular system, Standard, Cost Saving, NHS England Investment and Impact Fund (or browse all measures)

Sub-ICB Locations are ordered by mean percentile over the past six months. Each chart shows the results for the individual Sub-ICB Location, plus deciles across all Sub-ICB Locations in the NHS in England.

View measure for NHS England combined →

Fetching data...

Do you need help with your analysis? Don't forget to check the FAQ page, and if you have questions.